Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Multicenter Non-inferiority Trial of Nevirapine Plus Lamivudine Versus Optimal Standard in HIV Maintenance Therapy

NCT07014189 is registered in ClinicalTrials.gov with Cantonal Hospital of St. Gallen as lead sponsor.

NCT NCT07014189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07014189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Multicenter Non-inferiority Trial of Nevirapine Plus Lamivudine Versus Optimal Standard in HIV Maintenance Therapy
Lead sponsor
Cantonal Hospital of St. Gallen
Phase
Phase 4
Overall status
Completed
Start date
April 12, 2019
Completion date
August 31, 2023
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral treatment, hiv infection, maintenance therapy